Kestrel Group, Ltd.
NASDAQ:KGInsurance - Reinsurance
-$0.25 today
- Market cap
- $51.36M
- Beta
- 0.68
- P/E (TTM)
- 2.2
- EPS (TTM)
- $5.12
Volume 0.06M
Average 0.01M
KG Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Kestrel Group, Ltd.NASDAQ: KG
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
Research & Development vs competitors
How KG compares with its peers on the latest reported figures
No competitor Research & Development figures are available to compare.
Income Statement
Metric | FY2025 Dec 2025 |
|---|---|
| Revenue | 34.05M |
| Cost of Revenue | 8.99M |
| Gross Profit | 25.06M |
| Gross Margin | 73.6% |
| Research & Development | 0 |
| Selling, General & Admin | 0 |
| Operating Expenses | (24.55M) |
| Depreciation & Amortization | 94K |
| EBITDA | 59.57M |
| EBITDA Margin | 174.9% |
| Operating Income | 49.61M |
| Operating Margin | 145.7% |
| Interest Income | 0 |
| Interest Expense | 9.87M |
| Other Income / Expenses | 0 |
| Income Before Tax | 49.61M |
| Pre-Tax Margin | 145.7% |
| Income Tax Expense | 68K |
| Net Income | 46.73M |
| Net Margin | 137.2% |
| EPS (Basic) | 8.15 |
| EPS (Diluted) | 8.15 |
| Weighted Avg Shares | 5.73M |
| Weighted Avg Shares (Diluted) | 5.73M |
Kestrel Group, Ltd.
NASDAQ:KG
Intrinsic Alpha fair value
Locked
Current Price
$6.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.